Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study.
BACKGROUND
A better understanding of potentially modifiable predictors of in-hospital mortality and re-admission to the hospital following discharge may help to improve management of community-acquired pneumonia in older adults. We aimed to assess the associations of potentially modifiable factors with mortality and re-hospitalization in older adults hospitalized with community-acquired pneumonia.


METHODS
A prospective cohort study was conducted from July 2003 to April 2005 in two Canadian cities. Patients aged 65 years or older hospitalized for community-acquired pneumonia were followed up for up to 30 days from initial hospitalization for mortality and these patients who were discharged alive within 30 days of initial hospitalization were followed up to 90 days of initial hospitalization for re-hospitalization. Separate logistic regression analyses were performed identify the predictors of mortality and re-hospitalization.


RESULTS
Of 717 enrolled patients hospitalized for community-acquired pneumonia, 49 (6.8%) died within 30 days of hospital admission. Among these patients, 526 were discharged alive within 30 days of hospitalization of whom 58 (11.2%) were re-hospitalized within 90 days of initial hospitalization. History of hip fracture (odds ratio (OR) = 4.00, 95% confidence interval (CI) = (1.46, 10.96), P = .007), chronic obstructive pulmonary disease (OR = 2.31, 95% CI = (1.18, 4.50), P = .014), cerebrovascular disease (OR = 2.11, 95% CI = (1.03, 4.31), P = .040) were associated with mortality. Male sex (OR = 2.35, 95% CI = (1.13, 4.85), P = .022) was associated with re-hospitalization while vitamin E supplementation was protective (OR = 0.37 (0.16, 0.90), P = .028). Lower socioeconomic status, prior influenza and pneumococcal vaccinations, appropriate antibiotic prescription upon admission, and lower nutrition risk were not significantly associated with mortality or re-hospitalization.


CONCLUSIONS
Chronic comorbidities appear to be the most important predictors of death and re-hospitalization in older adults hospitalized with community-acquired pneumonia while vitamin E supplementation was protective.
Neupane
Binod
B
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Walter
Stephen D
SD
Krueger
Paul
P
Marrie
Tom
T
Loeb
Mark
M
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D017714:Community-Acquired Infections / Q000401:mortality / Q000628:therapy; D005260:Female; D017052:Hospital Mortality / Q000639:trends*; D006760:Hospitalization / Q000639:trends; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D008297:Male; D010359:Patient Readmission / Q000639:trends*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use; D011014:Pneumonia / Q000401:mortality* / Q000517:prevention & control / Q000628:therapy; D011237:Predictive Value of Tests; D011446:Prospective Studies; D016896:Treatment Outcome
D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines
J Clin Pharm Ther. 2004 Jun;29(3):231-9
15153084
Clin Infect Dis. 2003 Nov 15;37(10):1335-9
14583867
Med Clin (Barc). 2008 Jul 5;131(5):167-70
18674485
Heart Lung. 2004 Sep-Oct;33(5):301-7
15454909
Clin Microbiol Infect. 2008 Apr;14(4):322-9
18190569
Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):457-62
16773389
Diabetes Care. 2007 Sep;30(9):2251-7
17595354
Eur Respir J. 2005 Dec;26(6):1086-91
16319340
Clin Infect Dis. 2008 Feb 15;46(4):550-6
18194099
Arch Intern Med. 1997 Jan 13;157(1):36-44
8996039
J Am Geriatr Soc. 2006 Jul;54(7):1062-7
16866676
Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):159-66
16528540
Respir Care Clin N Am. 2005 Mar;11(1):99-108
15763225
Am J Public Health. 1997 May;87(5):811-6
9184511
Thorax. 2003 May;58(5):377-82
12728155
Eur Respir J. 2008 Jul;32(1):139-46
18287129
J Bone Miner Metab. 2006;24(2):100-4
16502115
N Engl J Med. 1981 Mar 12;304(11):638-42
7453741
Nutr Rev. 1996 Jan;54(1 Pt 2):S59-65
8919685
Ann N Y Acad Sci. 1992 Sep 30;669:125-39; discussion 139-40
1444019
Rev Med Chil. 2008 May;136(5):587-93
18769805
Medicine (Baltimore). 2003 May;82(3):159-69
12792302
Am J Respir Crit Care Med. 2002 Mar 15;165(6):766-72
11897642
Clin Infect Dis. 2000 Aug;31(2):383-421
10987698
Arch Intern Med. 1999 Nov 22;159(21):2562-72
10573046
Respir Care Clin N Am. 2005 Mar;11(1):15-24
15763218
Clin Infect Dis. 2000 Oct;31(4):1066-78
11049791
J Gen Intern Med. 2003 Apr;18(4):242-7
12709090
Int Disabil Stud. 1988;10(2):61-3
3403500
Annu Rev Nutr. 1997;17:101-25
9240921
Antimicrob Agents Chemother. 2007 Nov;51(11):3977-82
17709460
Am J Med. 2003 Oct 15;115(6):454-61
14563502
Eur Respir J. 2006 Aug;28(2):346-51
16611653
N Engl J Med. 1995 Dec 14;333(24):1618-24
7477199